Crossmark

A double-blind randomised controlled trial on the effect of Tocovid, a tocotrienol-rich capsule on postoperative atrial fibrillation at the National Heart Institute, Kuala Lumpur: an interim blinded analysis

Crossref DOI link: https://doi.org/10.1186/s13019-021-01721-6

Published Online: 2021-11-24

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Musa, Ahmad Farouk http://orcid.org/0000-0002-2303-7813
Dillon, Jeswant

Md Taib, Mohamed Ezani

Yunus, Alwi Mohamed

Sanusi, Abdul Rais

Nordin, Mohd Nazeri

Smith, Julian A.
Clinical Trials ^BETA

Clinical trials referenced in this document:

nct03807037 at ClinicalTrials.gov

Documents that mention this clinical trial

A double-blind randomised controlled trial on the effect of Tocovid, a tocotrienol-rich capsule on postoperative atrial fibrillation at the National Heart Institute, Kuala Lumpur: an interim blinded analysis
https://doi.org/10.1186/s13019-021-01721-6
Funding

Funding for this research was provided by:

hovid berhad (MMRD000001)

mpob (MMRD000002)
License Information

Text and Data Mining valid from 2021-11-24

Version of Record valid from 2021-11-24
More Information

Article History

Received: 5 August 2021

Accepted: 6 November 2021

First Online: 24 November 2021

Declaration

:

: No competing interests were disclosed.

Document is current

Any future updates will be listed below